EJ
Edward J Dulac III
DELAYED 1 MONTH
EVP, Chief Financial Officer
Intellia Therapeutics, Inc.
Filings
2
Companies
1
Latest
Jul 22, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
52
Intellia Therapeutics, Inc.
Edward J Dulac III
EVP, Chief Financial Officer
Sale
$91.2K
8,111 sh
Jul 24 9:26 PM
Jul 22, 2026